Publications by authors named "Georg Bohmig"

Claim this Profile
W
World Transplant Congress 2025 Highlights: Immunosuppression.
Georg A Böhmig, Aylin Akifova, Klemens Budde

Transplantation· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Kidney Paired Donation Programs: Evolution and Practices of 4 Large Collaborations.
Xenia Klimentova, Beatriz Domínguez-Gil, Ana Viana, David Manlove, Tommy Andersson

Transplantation· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection.
Roy Zhang, Colin Y C Lee, Martina Schatzl, Klemens Budde, Fabian Halleck

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection.
Thibaut Vaulet, Priyanka Koshy, Karolien Wellekens, Olivier Aubert, Charlotte Bottomley

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin for chronic active antibody-mediated rejection: a signal of hope in an evolving field.
Georg A Böhmig, Klemens Budde

Kidney Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of HLA desensitization in the management of renal transplant recipients in Europe.
Lionel P E Rostaing, Georg A Böhmig, Muhammed Mahdi Taqi, Ben Gibbons

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary Report of the CTS-TIREX Expert Meeting 2024 "Innovative Approaches to Immunogenetics and Organ Transplantation".
Caner Süsal, Idil Orhon, Georg A Böhmig, Lionel Rostaing, Klemens Budde

Transplantation· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated rejection-treatment standard.
Georg A Böhmig, Maarten Naesens, Ondrej Viklicky, Olivier Thaunat, Matthias Diebold

Nephrol Dial Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular inflammation in kidney allografts: New directions for patient management.
Georg A Böhmig, Alexandre Loupy, Marta Sablik, Maarten Naesens

Am J Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort Study.
Matthias Diebold, Hannes Vietzen, Martina Schatzl, Katharina A Mayer, Susanne Haindl

Transplantation· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system.
Yannis Lombardi, Marc Raynaud, Martina Schatzl, Katharina A Mayer, Matthias Diebold

Am J Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.
Lucrezia Furian, Uwe Heemann, Mats Bengtsson, Oriol Bestard, Isabelle Binet

Transpl Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluation.
Katharina A Mayer, Klemens Budde, Martina Schatzl, Eva Schrezenmeier, Matthias Diebold

Expert Opin Investig Drugs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional study of the role of epithelial cell injury in kidney transplant outcomes.
Philip F Halloran, Jessica Chang, Martina Mackova, Katelynn S Madill-Thomsen, Enver Akalin

JCI Insight· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients.
Klemens Budde, Bilgin Osmanodja, Eva Schrezenmeier, Fabian Halleck, Katharina A Mayer

Kidney Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.
Matthias Diebold, Patrick T Gauthier, Katharina A Mayer, Martina Mackova, Christian Hinze

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD38 in Antibody-Mediated Rejection.
Katharina A Mayer, Klemens Budde, Matthias Diebold, Philip F Halloran, Georg A Böhmig

Transpl Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Rejection After Kidney Transplantation.
Matthias Diebold, Katharina A Mayer, Luis Hidalgo, Nicolas Kozakowski, Klemens Budde

Transplantation· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Relaxation Time for the Prediction of Renal Transplant Dysfunction.
Haris Omić, Farsad Eskandary, Dietrich Beitzke, Marcos Wolf, Nicolas Kozakowski

Transpl Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Immunosuppressants in Pediatric Kidney Transplantation: What's in the Pipeline for Kids?
Burkhard Tönshoff, Christian Patry, Alexander Fichtner, Britta Höcker, Georg A Böhmig

Pediatr Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinions on the Future of Clinical Pig Kidney Xenotransplantation.
Georg A Böhmig, Matthias Diebold, Klemens Budde

Transpl Int· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX).
Roman Reindl-Schwaighofer, Andreas Heinzel, Lukas Raab, Robert Strassl, Carsten T Herz

EBioMedicine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Torque Teno Virus Control by the Classical Pathway of Complement Activation-A Retrospective Analysis From a First-in-Human Trial Utilizing Sutimlimab.
Sebastian Kapps, Jakob Mühlbacher, Dorian Kulifaj, Sophie Courjal, Farsad Eskandary

J Med Virol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation.
Philippe L Furlano, Georg A Böhmig, Elisabeth Puchhammer-Stöckl, Hannes Vietzen

Transplantation· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Felzartamab in Antibody-Mediated Rejection. Reply.
Georg A Böhmig, Uptal D Patel, Philip F Halloran

N Engl J Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis